| [1] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010,17(6):1471-1474.
|
| [2] |
National Comprehensive Cancer Network. Breast cancer.V1.2012 [EB/OL]. [2015-09-01]. http:/ /www. nccn. org/professionals/physician_gls/PDF/breast.pdf.
|
| [3] |
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol,2014,32(13):1365-1383.
|
| [4] |
Coates AS, Winer EP,Goldhirsch A,et al. Tailoring therapies- improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015[J]. Ann Oncol, 2015,26(8):1533-1546.
|
| [5] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2015)版[J]. 中国癌症杂志,2015, 25(9):692-754.
|
| [6] |
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J]. JAMA,2011,305(6):569-575.
|
| [7] |
Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer ( EORTC 10981-22023AMAROS ): randomised,multicenter, open-label, phase 3 non-inferiority trial [J].Lancet Oncol,2014,15(12):1303-1310.
|
| [8] |
Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy,total mastectomy, and total mastectomy followed by irradiation[J]. N Engl J Med,2002,347(8):567-575.
|
| [9] |
Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy results of a randomized study with 15 years of follow-up[J]. J Clin Oncol, 2004, 22(1):97-101.
|
| [10] |
Tan LK, Giri D, Hummer AJ, et al. Occult axillary node metastases in breast cancer are prognostically significant:results in 368 node-negative patients with 20-year follow-up[J]. J Clin Oncol,2008,26(11):1803-1809.
|
| [11] |
Wang YS, Wang CJ, Fan L, et al. Prognostic significance of sentinel nodes metastases in breast cancer patients without axillary node dissection and axillary radiotherapy CBCSG-001 Trial[J]. Cancer Res,2009,69(s2):108s.
|
| [12] |
de Boer M, van Deurzen CH, van Dijck JA, et al.Micrometastases or isolated tumor cells and the outcome of breast cancer[J]. N Engl J Med,2009,361(7):653-663.
|
| [13] |
Hunt KK, Ballman KV, McCall LM, et al. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial[J]. Ann Surg,2012,256(3):428-436.
|
| [14] |
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933.
|
| [15] |
Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases ( IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305.
|
| [16] |
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol,2014,32(13):1365-1383.
|
| [17] |
Wang YS, Wang CJ, Fan L, et al. Optimal detection of micrometastasis in sentinel lymph node of breast cancer:CBCSG-001trial[J]. Cancer Res,2009,69(s2):107s.
|
| [18] |
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance)clinical trial[J]. JAMA,2013,310(14):1455-1461.
|
| [19] |
Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy ( SENTINA ): A prospective,multicentre cohort study[J]. Lancet Oncol,2013,14(7):609-618.
|
| [20] |
Qiu PF, Liu JJ, Liu YB, et al. A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients[J].Breast Cancer Res Treat,2012,36(1):319-321.
|
| [21] |
Huang O,Wang L,Shen K,et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis:analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy[J]. Breast Cancer Res Treat,2003,107(3):379-387.
|
| [22] |
Qiu PF, Zhao RR, Liu YB, et al. Internal mammary sentinel lymph node biopsy should still be performed, especially in the patient with clinically positive axillary lymph nodes [J].Breast,2013,22(5):999-1000.
|
| [23] |
Poortmans PM,Collette S,Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer[J]. N Engl J Med,2015,373(4):317-327.
|
| [24] |
Thorsen LB, Offersen BV, Danø H, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[EB/OL].[2015-09-01]. http:/ /jco. ascopubs. org/content/early/2015/11/23/JCO.2015.63.6456.long.
|
| [25] |
Budach W, Kammers K, Boelke E, et al. Adjuvant radiotherapy of regional lymph nodes in breast cancer - a metaanalysis of randomized trials[J]. Radiat Oncol,2013, 8:267-273.
|
| [26] |
Cong BB, Qiu PF, Wang YS. Internal mammary sentinel lymph node biopsy: minimally invasive staging and tailored internal mammary radiotherapy[J]. Ann Surg Oncol,2014,21(7):2119-2121.
|